about
Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patientsThe role of drug transporters in the kidney: lessons from tenofovirTenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?Update on current management of chronic kidney disease in patients with HIV infectionHIV and kidney diseases: 35 years of history and consequencesEffect of changing from first- to second-line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia.Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report.Ganciclovir-tenofovir interaction leading to tenofovir-induced nephrotoxicity.Tenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in miceA consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.Tenofovir substitution in Namibia based on an analysis of the antiretroviral dispensing database.Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction.Woman with congenital HIV infection and medication-induced Fanconi syndrome.Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in ThailandTargeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda.Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free MiceHypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required.Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases.Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected ChildrenRenal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis BInsights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol.Small vessel microembolization and acute glomerulonephritis following infection of aesthetic filler implantsBrief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal MeningitisIs Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?Kidney disease in children and adolescents with perinatal HIV-1 infection.Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients.Low bone mineral density and associated risk factors in HIV-infected patients.Differences in Serum Levels of Magnesium, Phosphate, and Albumin for HAART-Experienced and HAART-Naïve Female Patients Attending Parirenyatwa Opportunistic Infections Clinic in Harare, ZimbabweThe effect of Tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis.Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?Nucleotide Analogue-Related Proximal Renal Tubular Dysfunction during Long-Term Treatment of Chronic Hepatitis B: A Cross-Sectional Study.Acute Kidney Injury, Risk Factors, and Prognosis in Hospitalized HIV-Infected Adults in South Africa, Compared by Tenofovir Exposure.Delayed onset renal failure in a patient on tenofovir based antiretroviral regimen.Impaired Urine Dilution Capability in HIV Stable Patients.Tenofovir Disoproxil Fumarate Is a New Substrate of ATP-Binding Cassette Subfamily C Member 11.Tenofovir Alafenamide.Vitamin D Status and Kidney Function Decline in HIV-Infected Men: A Longitudinal Study in the Multicenter AIDS Cohort Study.Editor's Highlight: Comparative Renal Safety Assessment of the Hepatitis B Drugs, Adefovir, Tenofovir, Telbivudine and Entecavir in Rats.Hypokalemic paralysis secondary to tenofovir induced fanconi syndrome
P2860
Q26770753-B71C5BB9-FC43-4BC4-8B16-BEAB2723C6D5Q26866489-B1D3846A-4B3E-4592-AB4A-2CCCAA5B9EBEQ26995852-AAFE6D53-44D8-48C6-8556-5224989FDA0EQ27691460-E45AD521-48E4-4A65-B7EF-2C740A4311C9Q28069641-D4EAB21F-6945-4070-8B9C-2B4B37C87A5CQ31108490-4DA844FE-2CCC-45A9-A21A-743AB8E857D5Q34139592-72B2F723-AF2C-482D-9353-CF400EECEF5AQ34509133-281CB3E0-82F5-4DB7-B5D3-878F3A7C371EQ35102322-1796A801-98B5-4490-A585-04B3E85444E7Q35149475-1C97539D-F858-439E-AF8D-555086A68609Q35534418-279731E1-779D-4D25-8928-2DAB2DF1E2FCQ35556516-6C0FB331-5AA1-4EB4-A867-B5EFFE121965Q35636495-951312EB-FE55-4CE4-9314-5A9969D80334Q35864595-CE8D151F-4EB3-4423-A3A8-337E9C133B12Q35981062-B210BCD5-6E51-4504-97CB-658CF7DC9746Q36027794-B63278DF-08E1-4FF6-BFD5-E0D0E262E633Q36033710-FC59C999-9CA1-4A99-80EC-4FD87233CDE9Q36067839-8339F9B4-776A-44D5-B081-A6139E6D4AAEQ36070335-63299CAE-697D-4329-9FF7-4D24E3E8E3FBQ36238754-75204C67-21A6-4ECD-BCA6-E736C404A820Q36439125-3EAB3698-67F9-433C-8FC2-CDEA5E99FFDBQ36446410-42E9FC9E-4CCE-4A12-B198-B0EADCE84B26Q36463811-FCD1B22C-E619-4F80-A8CD-99C4CFB47AA4Q36576316-A3A6FA85-5458-401E-9534-2C3D71275C8CQ36942310-F8BD33C9-3B0C-4382-A825-68E5165B91E1Q37111444-EA5B287A-6F2D-43B8-A025-12E8D86CDF23Q37115224-CC7C38BF-0BAF-4482-B6D7-719C68BCE6F1Q37182852-657DD543-5DFB-442D-BABF-96065F0F8954Q37221374-B7D90A67-0462-4A82-A443-59FE685E0BFCQ37238911-586911B4-718F-414D-9F0D-211FCF7BE533Q37263395-CA1445AB-E86A-4680-AFF0-762C62BB2261Q37411624-C2459B0C-27EA-45D0-9A5E-5D06CBCBCE1BQ37588780-F897FEB9-2F32-4C60-93E4-0EF376F8EDA6Q37703573-BEC96231-922A-4108-A6E8-8E1E70EF832CQ37706095-4F098534-150D-48F2-B080-6ADF8D6EB64CQ38717612-AA1DBDB5-52D2-42D4-B696-23A8A563AE5DQ38910661-A6F28F48-FBE0-4E13-8CC2-A75818B6FA76Q40102586-AE279ED1-4D06-4C77-9F05-B2CDC2582EC6Q40541312-728E0EA0-D5E1-4D79-AFAF-E904E5918545Q40861687-5F30CEB7-5634-4F7F-8391-2F053E8204EE
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tenofovir nephrotoxicity: 2011 update.
@en
Tenofovir nephrotoxicity: 2011 update.
@nl
type
label
Tenofovir nephrotoxicity: 2011 update.
@en
Tenofovir nephrotoxicity: 2011 update.
@nl
prefLabel
Tenofovir nephrotoxicity: 2011 update.
@en
Tenofovir nephrotoxicity: 2011 update.
@nl
P2093
P2860
P50
P356
P1476
Tenofovir nephrotoxicity: 2011 update.
@en
P2093
Alejandro Parra-Rodriguez
Ana Montoya-Ferrer
Beatriz Fernandez-Fernandez
Jesus Egido
Jonay Poveda
Maria C Izquierdo
Natalia Ortiz-Martin
Rafael Selgas
Valeria Sainz-Prestel
P2860
P304
P356
10.1155/2011/354908
P577
2011-06-07T00:00:00Z